[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Cho Hyun-ui] The number of reported adverse events following vaccination with the influenza (flu) vaccine, from which white particles were discovered and subsequently recalled, has increased by one case.


On the 13th, the Ministry of Food and Drug Safety disclosed the 'Investigation Results of Vaccines Confirmed with White Particles' at the National Assembly Health and Welfare Committee's audit session. While only one adverse event was reported at the initial announcement, the total has now risen to two cases.


White particles resembling white sediment were found in some batches of Korea Vaccine's flu vaccine 'Kovax Flu Quadrivalent PF Injection,' leading the manufacturer to voluntarily recall 615,000 doses of the problematic vaccine. As of the 9th, 17,812 people had been vaccinated with the recalled vaccine.


All adverse events involved localized pain at the injection site. However, the Ministry of Food and Drug Safety emphasized that safety concerns are minimal.



The director stated, "All flu vaccines in which white particles were found met the standards at the time of shipment, and the issue appeared only when a specific syringe was filled with a specific company's raw material," adding, "It seems that the problem was caused by a specific raw material and syringe, reflecting a physical effect of shaking during the distribution process."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing